| Literature DB >> 33536801 |
Yang Zhou1,2, Wen Peng1,2, Guifang Yang1,2, Xiaogao Pan1,2, Ning Ding1,2, Hongliang Zhang1,2, Zhenyu Peng1,2, Dongshan Zhang1,2, Sijie Wu3, Xiangping Chai1,2.
Abstract
BACKGROUND: The management of acute aortic dissection (AAD) has improved; however, the outcomes related to different gender with short-term outcomes in non-surgically managed AAD with hypertension are still limited. Our objective was to explore gender-differences in association with short-term outcomes of patients comorbid with hypertension in non-surgically managed AAD.Entities:
Keywords: aortic dissection; gender-differences; hypertension; short-term outcomes
Year: 2021 PMID: 33536801 PMCID: PMC7850566 DOI: 10.2147/RMHP.S289943
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Figure 1Flowchart of participant enrollment.
Baseline Characteristics
| Variables | Overall (%) n=288 | Male (%) n=238 | Female (%) n=50 | |
|---|---|---|---|---|
| Age, year | 55.72 ± 12.13 | 55.30 ± 12.44 | 57.74 ± 10.39 | 0.196 |
| Systolic blood pressure, mmHg | 145.85 ± 31.68 | 145.40 ± 30.97 | 147.94 ± 35.11 | 0.608 |
| Diastolic blood pressure, mmHg | 81.75 ± 19.41 | 81.63 ± 19.36 | 82.32 ± 19.80 | 0.819 |
| Heart rate, beats/min | 83.54 ± 15.70 | 83.42 ± 16.21 | 84.16 ± 13.04 | 0.776 |
| Drinking | 38 (13.19) | 36 (15.13) | 2 (4.00%) | 0.035 |
| Smoking | 91 (31.60) | 87 (36.55) | 4 (8.00) | <0.001 |
| Diabetes | 14 (4.86) | 7 (2.94) | 7 (14.00) | <0.001 |
| Stroke | 20 (6.94) | 15 (6.30) | 5 (10.00) | 0.350 |
| Atherosclerosis | 40 (13.89) | 34 (14.29) | 6 (12.00) | 0.671 |
| Marfan syndrome | 4 (1.39) | 3 (1.26) | 1 (2.00) | 0.685 |
| Chronic kidney | 8 (2.78) | 7 (2.94) | 1 (2.00) | 0.713 |
| Symptoms | 0.090 | |||
| Chest pain | 201 (69.79) | 170 (71.43) | 31 (62.00) | |
| Abdominal pain | 25 (8.68) | 22 (9.24) | 3 (6.00) | |
| Back pain | 17 (5.90) | 15 (6.30) | 2 (4.00) | |
| Syncope | 5 (1.74) | 4 (1.68) | 1 (2.00) | |
| Other | 40 (13.89) | 27 (11.34) | 13 (26.00) |
Figure 2The incidence of AAD and in-hospital mortality in the different age groups. (A) The incidence of AAD with different gender in different age groups. (B) The incidence of in-hospital mortality with different gender in the different age groups.
Laboratory Testing and Imaging Characteristics
| Variables | Overall (%) n=288 | Male (%) n=238 | Female (%) n=50 | |
|---|---|---|---|---|
| White blood cell, ×109 | 11.36 ± 4.54 | 11.48 ± 4.52 | 10.82 ± 4.64 | 0.353 |
| Platelet, ×109 | 182.03 ± 80.85 | 182.02 ± 75.47 | 182.08 ± 104.06 | 0.996 |
| Uric acid, umol/L, (IQR) | 369.9 (276.6, 447.35) | 373.9 (280.12, 465.6) | 318.3 (224.2, 419) | 0.009 |
| Creatinine, umol/L, (IQR) | 97.9 (74.6, 148.9) | 100.5 (77.9, 152.6) | 79.5 (62.4, 137.6) | 0.007 |
| Prothrombin time, s | 14.29 ± 2.93 | 14.22 ± 2.31 | 14.62 ± 5.02 | 0.411 |
| Activated partial thromboplastin time, s | 39.80 ± 10.13 | 40.10 ± 10.17 | 38.26 ± 9.86 | 0.277 |
| D-dimer, (IQR) | 4.86 (2.18, 15.10) | 4.88 (2.26, 14.48) | 4.17 (1.98, 17.60) | 0.688 |
| Left ventricular ejection fraction, % | 0.260 | |||
| 20–40 | 2 (1.23) | 2 (1.46) | 0 (0.00) | |
| 41–60 | 22 (13.50) | 16 (11.68) | 6 (23.08) | |
| >60 | 139 (85.28) | 119 (86.86) | 20 (76.92) | |
| Aortic regurgitation | 0.089 | |||
| Mild | 61 (59.80) | 54 (62.79) | 7 (43.75) | |
| Moderate | 17 (16.67) | 11 (12.79) | 6 (37.50) | |
| Severe | 4 (3.92) | 3 (3.49) | 1 (6.25) | |
| Stanford type | 0.839 | |||
| Type A | 142 (49.31) | 118 (49.58) | 24 (48.00) | |
| Type B | 146 (50.69) | 120 (50.42) | 26 (52.00) | |
| Abdominal vessel involvement | 74 (25.69) | 60 (25.21) | 14 (28.00) | 0.681 |
| Arch vessel involvement | 51 (45.95) | 44 (46.32) | 7 (43.75) | 0.849 |
| Cardiac tamponade | 35 (28.23) | 26 (25.00) | 9 (45.00) | 0.069 |
| Pleural effusion | 64 (49.61) | 52 (46.85) | 12 (66.67) | 0.119 |
Abbreviation: IQR, interquartile range.
Treatment and Primary Outcomes
| Variables | Overall (%) n=288 | Male (%) n=238 | Female (%) n=50 | P-value |
|---|---|---|---|---|
| Nitrate drugs | 159 (55.21) | 135 (60.27) | 24 (53.33) | 0.767 |
| Angiotensin-converting enzyme inhibitor | 21 (7.81) | 17 (7.59) | 4 (8.89) | 0.767 |
| Angiotensin receptor blocker | 86 (31.97) | 77 (34.38) | 9 (20.00) | 0.059 |
| β-blockers | 196 (72.86) | 163 (72.77) | 33 (73.33) | 0.938 |
| Calcium channel blockers | 151 (56.13) | 129 (57.59) | 22 (48.89) | 0.283 |
| In-hospital mortality | 171 (59.38) | 134 (56.30) | 37 (74.00) | 0.021 |
Figure 3Comparison of in-hospital mortality stratified by the different gender.
Figure 4Kaplan–Meier curves for in-hospital survival according to different gender in non-surgically managed acute aortic dissection patients with hypertension.
Figure 5The effect of female sex on outcomes following multivariable analysis. Model 1: adjust for none. Model 2: adjust for: age, SBP, DBP. Model 3: age, SBP, DBP, stroke, diabetes, CKD, CHD, drinking, smoking, symptom, type.